Dr. Feng Tao is an Associate Professor in the Department of Biomedical Sciences at Texas A&M
University College of Dentistry. Dr. Tao received his RO1 award and Independent Scientist Award
from NIH in 2012 and 2014, respectively. He has published more than 40 papers in peer-reviewed
professional journals and he is serving as an editorial board member for some professional
journals. Dr. Tao also served as an invited reviewer for NIH NRCS Study Section, Johns Hopkins
ACCM Seed Grant, NSF-sponsored Pilot Funding at Louisiana State University, Arizona
Biomedical Research Commission, Britain Israel Research and Academic Exchange Partnership
Regenerative Medicine Initiative, Wings for Lifeâˆ’Spinal Cord Research Foundation in Austria,
Department of Veterans Affairs Rehabilitation Research and Development Service Spinal Cord
Injury and Neuropathic Pain Panel, and The French National Research Agency (ANR) in France.
Dr. Robert Gyula Almasi began his postgraduate studies at â€œKaposi Morâ€ Teaching Hospital in Hungary and specialized in Anesthesiology and Intensive Care. He held various lectures in the Faculty of Health Sciences at Pecs University. He was interested in acute and chronic pain management and joined the Institute of Pharmacology at University of Pecs Medical School as Associate Researcher in the Program of Neuroscience, Pain Pharmacology. In 2008 he received a Ph.D.from the same university. He was the Head of Dept. of Anesth. and Pain Management.
Dr. Almasi was studying interventional pain management and ultrasound-guided peripheral nerve blockade techniques. He joined the Institute of Anaesthesiology and Intensive Care at Pecs University as a practicing regional anesthesiologist and pain expert and became a Senior Lecturer teaching various lectures and courses mainly in pain pharmacology, pain management, and regional anesthesia. He has been a member of IASP since 2006.With his colleagues and Ph.D. students his recent research interests include studying the effects of peripheral nerve blockades on perioperative and chronic pain, and the endocannabinoids
Dr. Nagy his graduation as an MD at University Medical School Debrecen, Hungary in 1982, Dr Nagy started to work as a neuroscientist. He obtained his PhD at the Hungarian Academy of Sciences in 1996. Recently he has also obtained the title of Dr. Habil.
Dr Nagy has been working at Imperial College London since 1998, where he is one of the leading basic pain scientists. His pioneering work on heat transduction mechanisms and interactions between the endovanilloid and endocannabinoid systems has significantly contributed to the knowledge, which underlies the recent development of novel pharmacological approaches for pain control.
ISTVAN NAGY(Research Area)
Dr Nagy has been working on transduction mechanisms in primary sensory neurons for more than 10 years. Currently Dr Nagy and his co-workers are interested in the mechanisms in mechanotransduction, particulalry in those which are involved the development of inflmmatory visceral hyper-reflexia.
Endocannabinoid and endocannabinoid system:
In order to utalise the potential of the endovanilloid and endocannabinoid systems for pain control, Dr Nagy and his co-workers study the role of various enocannabinoid/endovanoilloid molecules on the rugulation of nociceptive processing in primary sensory neurosn and the spinal cord. In this work they pay particular attention on the role of anandamide, by studying the actions and metabolism of this molecule.
Nociceptive mechanisms in burn injury:
In order to increase our understanding of the peripheral signalling mechanisms involved in the development of burn injury-associated pain, and to identify new target(s) for the development of novel analgesics for controlling burn injury-associated pain, Dr Nagy' laboratory is engaged in studies on signalling between agents accumulating in burnt tissues and sensory nerve endings innervating burnt tissues. In this work, Dr Nagy and his co-workers generate metabolomic and gene expression tissue databases of various degrees of burn injury (volunteer, burn-injured patients and rats) and rat primary sensory neurons, respectively. Analysing these databases will reveal putative targets for new therapeutic approaches to control pain in burn-injured patients.
Dr Nagy has recently started to study mechanisms involved in the development of tension headache and migraine. He and his co-workers are particulalry interested in the role of hypothalamus, and mechanotransduction in trigeminal ganglionic neurons in the development of headache.
Dr. Brinkers has completed his MD at the university of Bonn. His postdoctoral studies are based on the habilitation thesis about the influence of CL on pain therapy. He is now senior house officer at the pain clinic of the university Magdeburg.
Robert J. Gatchel, PhD, ABPP, is professor in the Department of Psychology, College of Science, at the University of Texas at Arlington. He is the Director of the Center for Excellence for the Study of Health & Chronic Illness at the University of Texas at Arlington, as well as Director of Biopsychosocial Research, Osteopathic Research Center, University of North Texas Health Science Center. He also is clinical research program consultant at the Eugene McDermott Center for Pain Management at the University of Texas Southwestern Medical Center at Dallas. Dr. Gatchel is a member of the Practical Pain Management Editorial Board.
Robert J Gatchel(Research Area)
Comorbidity of Physical and Mental Health Conditions.
Etiology, Assessment, and Treatment of Chronic Pain Behavior. Evaluation of Stress-Management Treatment Techniques. Psycho physiological Concomitants of Stress and Emotion.
Dr. Farnad Imani is an associate professor with sixteen years' experience in academic postgraduate teaching in anesthesiology and pain medicine. He is chairman of department of anesthesiology and pain medicine in Tehran University of Medical Sciences (TUMS). He is founder of academic pain fellowship in Iran at 2006, and established the pain ward and interventional pain operation room in Rasoul Akram Medical Center at the first time in Iran. Dr. Imani has passed a course of interventional pain procedures in Texas Tech University, USA, in 2008, and is a Fellowship of the Interventional Pain Practice (FIPP) and secretory of World Institute of Pain (WIP), Iran section. He is founder and president of the Iranian Society of Regional Anesthesia and Pain Medicine (ISRAPM) from 2007 until now. Also, he conducts numerous seminars in the field of Interventional Pain Management, and was chairman of some Congresses of Interventional Pain Medicine. Dr Imani is pioneer of some Interventional Pain Procedures, such as percutaneous disc decompression, kyphoplasty, epiduroscopy, and radiofrequency (RF) neurolysis in Iran. He has conducted several workshops on interventional pain procedures, and invited speaker for several International congresses. Dr Imani is founder, chairman and editor in chief of Anesthesiology and Pain Medicine, which is the official Journal of ISRAPM. The journal welcomes all kinds of manuscripts which relevant to anesthesiology and pain Medicine field. He is the author of several papers in national and international journals, and books in the fields of anesthesiology and pain medicine (Persian language). He is going to authorize a pain book as the first comprehensive pain textbook in Persian language. Dr. Imani is the medical director and founder of the Mahya Pain Clinic. Until today, he continues to strive to be at the forefront for the treatment all spine and pain disorders. His passion for providing the most advanced medical and interventional pain technologies has made him well recognized in the field of pain management.